Jasxcjm的个人主页 - 老虎社区

Jasxcjm

Jasxcjm

暂无个人介绍

IP属地：未知

55关注

7粉丝

0主题

0勋章

2021-12-18

Target (TGT) - The stock price of TGT does not justify the judgmentals.

2021-12-17

Hmmm

2021-06-27

Hehe baidu

抱歉，原内容已删除

2021-06-24

Damn son

Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval

2021-06-24

Yes

BoE Keeps Rates, QE Unchanged; Won't Tighten Until "Clear Evidence Of Progress" Toward Inflation Goal

2021-06-21

Like and comment pls? :)

抱歉，原内容已删除

2021-06-21

Hi pls like and comment!

抱歉，原内容已删除

2021-04-02

Haha

Wall Street Has Given Up on These 3 Stocks, and That's a Huge Mistake

2021-02-23

Buy more at trend reversal

Tesla Stock Is in a Bear Market. It’s Taking Other EV Stocks With It.

2021-01-30

[难过] [难过] [难过]

抱歉，原内容已删除

2021-01-28

Apps

抱歉，原内容已删除

2021-01-25

It’s time

Australia shares end at 11-month high as country approves Pfizer vaccine

2021-01-22

Oh no

抱歉，原内容已删除

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3562381348726197","uuid":"3562381348726197","gmtCreate":1599294231164,"gmtModify":1599315355899,"name":"Jasxcjm","pinyin":"jasxcjm","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/30d8e49d33f2e14f0349d94e1a091311","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":7,"headSize":55,"tweetSize":13,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":3,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.54%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.01.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.54%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":699511362,"gmtCreate":1639837416665,"gmtModify":1639837416800,"author":{"id":"3562381348726197","authorId":"3562381348726197","name":"Jasxcjm","avatar":"https://static.tigerbbs.com/30d8e49d33f2e14f0349d94e1a091311","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562381348726197","idStr":"3562381348726197"},"themes":[],"htmlText":"Target (TGT) - The stock price of TGT does not justify the judgmentals.&nbsp;","listText":"Target (TGT) - The stock price of TGT does not justify the judgmentals.&nbsp;","text":"Target (TGT) - The stock price of TGT does not justify the judgmentals.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/699511362","isVote":1,"tweetType":1,"viewCount":1463,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690721649,"gmtCreate":1639710812581,"gmtModify":1639710812707,"author":{"id":"3562381348726197","authorId":"3562381348726197","name":"Jasxcjm","avatar":"https://static.tigerbbs.com/30d8e49d33f2e14f0349d94e1a091311","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562381348726197","idStr":"3562381348726197"},"themes":[],"htmlText":"Hmmm&nbsp;","listText":"Hmmm&nbsp;","text":"Hmmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690721649","isVote":1,"tweetType":1,"viewCount":2485,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":124312824,"gmtCreate":1624736715668,"gmtModify":1631886632729,"author":{"id":"3562381348726197","authorId":"3562381348726197","name":"Jasxcjm","avatar":"https://static.tigerbbs.com/30d8e49d33f2e14f0349d94e1a091311","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562381348726197","idStr":"3562381348726197"},"themes":[],"htmlText":"Hehe baidu&nbsp;","listText":"Hehe baidu&nbsp;","text":"Hehe baidu","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/124312824","repostId":"1164137597","repostType":4,"isVote":1,"tweetType":1,"viewCount":2458,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":126090610,"gmtCreate":1624535869630,"gmtModify":1631886632742,"author":{"id":"3562381348726197","authorId":"3562381348726197","name":"Jasxcjm","avatar":"https://static.tigerbbs.com/30d8e49d33f2e14f0349d94e1a091311","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562381348726197","idStr":"3562381348726197"},"themes":[],"htmlText":"Damn son&nbsp;","listText":"Damn son&nbsp;","text":"Damn son","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/126090610","repostId":"1113369372","repostType":4,"repost":{"id":"1113369372","kind":"news","pubTimestamp":1624535308,"share":"https://www.laohu8.com/m/news/1113369372?lang=&edition=full","pubTime":"2021-06-24 19:48","market":"us","language":"en","title":"Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1113369372","media":"The Wall Street Journal","summary":"(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after th","content":"<p><i><b>(Update: June 24, 2021 at 09:32 a.m. ET)</b></i></p>\n<p>Eli Lilly shares jumped over 8% in&nbsp;morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.</p>\n<p><img src=\"https://static.tigerbbs.com/9b4cea69bed4d928fd18195924788827\" tg-width=\"658\" tg-height=\"438\"></p>\n<p>The move is meant to expedite the development and review of the experimental treatment.</p>\n<p>Rival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 19:48 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from ...</p>\n\n<a href=\"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LLY":"礼来"},"source_url":"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1113369372","content_text":"(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.\n\nThe move is meant to expedite the development and review of the experimental treatment.\nRival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.","news_type":1,"symbols_score_info":{"LLY":0.9}},"isVote":1,"tweetType":1,"viewCount":1359,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":126090081,"gmtCreate":1624535844543,"gmtModify":1631886632755,"author":{"id":"3562381348726197","authorId":"3562381348726197","name":"Jasxcjm","avatar":"https://static.tigerbbs.com/30d8e49d33f2e14f0349d94e1a091311","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562381348726197","idStr":"3562381348726197"},"themes":[],"htmlText":"Yes","listText":"Yes","text":"Yes","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/126090081","repostId":"1191442444","repostType":4,"repost":{"id":"1191442444","kind":"news","pubTimestamp":1624534197,"share":"https://www.laohu8.com/m/news/1191442444?lang=&edition=full","pubTime":"2021-06-24 19:29","market":"uk","language":"en","title":"BoE Keeps Rates, QE Unchanged; Won't Tighten Until \"Clear Evidence Of Progress\" Toward Inflation Goal","url":"https://stock-news.laohu8.com/highlight/detail?id=1191442444","media":"zerohedge","summary":"With central banks riding a hawkish wave in recent months, eyes turned toward the Bank of England an","content":"<p>With central banks riding a hawkish wave in recent months, eyes turned toward the Bank of England and its latest monetary policy decision this morning, which however did not surprise as the central bank voted unanimously to keep interest rates at 0.1% and by a majority of 8-1 to maintain the amount of quantitative easing at £895bn, with outgoing chief economist Haldane again dissenting and voting to reduce the asset purchase target in his final vote before leaving the Bank of England.</p>\n<p><img src=\"https://static.tigerbbs.com/ee2372b645665ef729732f7accedac5e\" tg-width=\"510\" tg-height=\"538\"></p>\n<p>So with inflation surging in the UK as everywhere else, how did the BOE deflect calls to tighten? Simple, like the Fed it said that while inflation may rise above 3%, it will be transitory, to wit: \"<i>CPI inflation is expected to pick up further above the target, owing primarily to developments in energy and other commodity prices,</i><i><b>and is likely to exceed 3% for a temporary period</b></i><i>\"</i>which means June output is expected to be around 2.5% below its pre-Covid level in the final quarter of 2019. For context, the previous inflation peak was projected to be 2.5%, so yet another significant reflationary rethink.</p>\n<p>And once said \"temporary period\" ends, all shall be well, however nobody knows when that will be, just as nobody knows what the<b>\"clear evidence of significant progress\"</b>toward achieving the 2% inflation target is that the BOE needs before tightening policy.</p>\n<p>And while the BOE won't issue a fresh round of forecasts until August, they did revise up their second-quarter projection by around 1.5 percentage points from their May projection of 4.3%.</p>\n<p>Some more details from thefull statement:</p>\n<ul>\n <li>Committee’s expectation is that the direct impact of rises in commodity prices on CPI inflation will be transitory.</li>\n <li>Output in a number of sectors is now around pre-Covid levels, although it remains materially below in others</li>\n <li>Developments in global GDP growth have been somewhat stronger than anticipated, particularly in advanced economies</li>\n <li>The Committee does not intend to tighten monetary policy at least until there is clear evidence that significant progress is being made in eliminating spare capacity and achieving the 2% inflation target sustainably.</li>\n <li>Spare capacity in the economy was expected to be eliminated as activity picked up, and there was expected to be a temporary period of excess demand, before demand and supply returned broadly to balance.</li>\n <li>Policy should both lean strongly against downside risks to the outlook and ensure that the recovery was not undermined by a premature tightening in monetary conditions.</li>\n <li>Most members judged that the conditions set out in the MPC’s existing policy guidance, which were in any case necessary but not sufficient conditions for any future tightening in monetary policy, were not met.</li>\n <li>Bank staff had revised up their expectations for 2021 Q2 GDP growth to 5.5%, from 4.25% at the&nbsp; time of the May Report. That would be consistent with output in Q2 being less than 4% below its 2019 Q4 level, and projected output in June around 2.5% lower.</li>\n <li>It was possible that a stronger path for demand would close the output gap somewhat sooner than had previously been expected.</li>\n</ul>\n<p>The market response was muted as the decision appeared to come on the dovish side: the pound reversed modest gains as short-term positioning over a hawkish surprise is unwound. Gilts rise, with 10-year yield down by 3 basis points to 0.75%.</p>\n<p><img src=\"https://static.tigerbbs.com/7010feb093662e50703d0e073ffbf258\" tg-width=\"500\" tg-height=\"242\"></p>\n<p>According to Bloomberg, in the longer term, and until a shift comes, the pound may stay under pressure especially as it trades below its 21-weekly moving average, a momentum-defining indicator since the pandemic started.</p>\n<p>At the same time, EUR/GBP rallied as stops were triggered given the transitory-inflation narrative remains and cable dips toward the $1.39 handle. According to Bloomberg,<b>a 15bps rate hike by the BOE is now pushed back to Aug 2022 from June 2022 just before the decision.</b>It remains to be seen whether this is more interest to trade the pound afresh or is it all down to short-term position rebalancing.</p>\n<p>Bottom line: today's somewhat dovish statements puts a lot of attention on to the August meeting when we’ll get a full set of new forecasts and learn more about the BOE's thinking; we should also have a clearer sense of how the virus situation is developing once more people are vaccinated.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BoE Keeps Rates, QE Unchanged; Won't Tighten Until \"Clear Evidence Of Progress\" Toward Inflation Goal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBoE Keeps Rates, QE Unchanged; Won't Tighten Until \"Clear Evidence Of Progress\" Toward Inflation Goal\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 19:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.zerohedge.com/markets/boe-keeps-rates-qe-unchanged-wont-tighten-until-clear-evidence-progress-toward-inflation><strong>zerohedge</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>With central banks riding a hawkish wave in recent months, eyes turned toward the Bank of England and its latest monetary policy decision this morning, which however did not surprise as the central ...</p>\n\n<a href=\"https://www.zerohedge.com/markets/boe-keeps-rates-qe-unchanged-wont-tighten-until-clear-evidence-progress-toward-inflation\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.zerohedge.com/markets/boe-keeps-rates-qe-unchanged-wont-tighten-until-clear-evidence-progress-toward-inflation","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1191442444","content_text":"With central banks riding a hawkish wave in recent months, eyes turned toward the Bank of England and its latest monetary policy decision this morning, which however did not surprise as the central bank voted unanimously to keep interest rates at 0.1% and by a majority of 8-1 to maintain the amount of quantitative easing at £895bn, with outgoing chief economist Haldane again dissenting and voting to reduce the asset purchase target in his final vote before leaving the Bank of England.\n\nSo with inflation surging in the UK as everywhere else, how did the BOE deflect calls to tighten? Simple, like the Fed it said that while inflation may rise above 3%, it will be transitory, to wit: \"CPI inflation is expected to pick up further above the target, owing primarily to developments in energy and other commodity prices,and is likely to exceed 3% for a temporary period\"which means June output is expected to be around 2.5% below its pre-Covid level in the final quarter of 2019. For context, the previous inflation peak was projected to be 2.5%, so yet another significant reflationary rethink.\nAnd once said \"temporary period\" ends, all shall be well, however nobody knows when that will be, just as nobody knows what the\"clear evidence of significant progress\"toward achieving the 2% inflation target is that the BOE needs before tightening policy.\nAnd while the BOE won't issue a fresh round of forecasts until August, they did revise up their second-quarter projection by around 1.5 percentage points from their May projection of 4.3%.\nSome more details from thefull statement:\n\nCommittee’s expectation is that the direct impact of rises in commodity prices on CPI inflation will be transitory.\nOutput in a number of sectors is now around pre-Covid levels, although it remains materially below in others\nDevelopments in global GDP growth have been somewhat stronger than anticipated, particularly in advanced economies\nThe Committee does not intend to tighten monetary policy at least until there is clear evidence that significant progress is being made in eliminating spare capacity and achieving the 2% inflation target sustainably.\nSpare capacity in the economy was expected to be eliminated as activity picked up, and there was expected to be a temporary period of excess demand, before demand and supply returned broadly to balance.\nPolicy should both lean strongly against downside risks to the outlook and ensure that the recovery was not undermined by a premature tightening in monetary conditions.\nMost members judged that the conditions set out in the MPC’s existing policy guidance, which were in any case necessary but not sufficient conditions for any future tightening in monetary policy, were not met.\nBank staff had revised up their expectations for 2021 Q2 GDP growth to 5.5%, from 4.25% at the  time of the May Report. That would be consistent with output in Q2 being less than 4% below its 2019 Q4 level, and projected output in June around 2.5% lower.\nIt was possible that a stronger path for demand would close the output gap somewhat sooner than had previously been expected.\n\nThe market response was muted as the decision appeared to come on the dovish side: the pound reversed modest gains as short-term positioning over a hawkish surprise is unwound. Gilts rise, with 10-year yield down by 3 basis points to 0.75%.\n\nAccording to Bloomberg, in the longer term, and until a shift comes, the pound may stay under pressure especially as it trades below its 21-weekly moving average, a momentum-defining indicator since the pandemic started.\nAt the same time, EUR/GBP rallied as stops were triggered given the transitory-inflation narrative remains and cable dips toward the $1.39 handle. According to Bloomberg,a 15bps rate hike by the BOE is now pushed back to Aug 2022 from June 2022 just before the decision.It remains to be seen whether this is more interest to trade the pound afresh or is it all down to short-term position rebalancing.\nBottom line: today's somewhat dovish statements puts a lot of attention on to the August meeting when we’ll get a full set of new forecasts and learn more about the BOE's thinking; we should also have a clearer sense of how the virus situation is developing once more people are vaccinated.","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":2267,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":167811362,"gmtCreate":1624257911556,"gmtModify":1631886632768,"author":{"id":"3562381348726197","authorId":"3562381348726197","name":"Jasxcjm","avatar":"https://static.tigerbbs.com/30d8e49d33f2e14f0349d94e1a091311","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562381348726197","idStr":"3562381348726197"},"themes":[],"htmlText":"Like and comment pls? :)&nbsp;","listText":"Like and comment pls? :)&nbsp;","text":"Like and comment pls? :)","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/167811362","repostId":"1154249454","repostType":4,"isVote":1,"tweetType":1,"viewCount":2078,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":164241327,"gmtCreate":1624214414669,"gmtModify":1631886632779,"author":{"id":"3562381348726197","authorId":"3562381348726197","name":"Jasxcjm","avatar":"https://static.tigerbbs.com/30d8e49d33f2e14f0349d94e1a091311","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562381348726197","idStr":"3562381348726197"},"themes":[],"htmlText":"Hi pls like and comment!&nbsp;","listText":"Hi pls like and comment!&nbsp;","text":"Hi pls like and comment!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/164241327","repostId":"1199331995","repostType":4,"isVote":1,"tweetType":1,"viewCount":2178,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":340177912,"gmtCreate":1617366112936,"gmtModify":1631886632793,"author":{"id":"3562381348726197","authorId":"3562381348726197","name":"Jasxcjm","avatar":"https://static.tigerbbs.com/30d8e49d33f2e14f0349d94e1a091311","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562381348726197","idStr":"3562381348726197"},"themes":[],"htmlText":"Haha","listText":"Haha","text":"Haha","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/340177912","repostId":"1121666420","repostType":4,"repost":{"id":"1121666420","kind":"news","pubTimestamp":1617365764,"share":"https://www.laohu8.com/m/news/1121666420?lang=&edition=full","pubTime":"2021-04-02 20:16","market":"us","language":"en","title":"Wall Street Has Given Up on These 3 Stocks, and That's a Huge Mistake","url":"https://stock-news.laohu8.com/highlight/detail?id=1121666420","media":"Motley Fool","summary":"It's never a bad time to search for beaten-down stocks that are profitable on paper.Searching forval","content":"<blockquote>It's never a bad time to search for beaten-down stocks that are profitable on paper.</blockquote><p>Searching forvalue stocksis pretty simple: Find financially robust companies that have performed poorly from a share price perspective, and buy them when they're down. When the share price comes back to reality, you'll be a winner. Wall Street has the habit of kicking a stock when it's down, as negative sentiment surrounding a particular name can spell doom for shareholders.</p><p>For those seeking value, these moments present an opportunity. Here, we'll look at three value stocks that have seen better days, but also have a good chance at rebounding.</p><p><b>Gilead Sciences</b></p><p>Over the past five years,<b>Gilead Sciences</b>(NASDAQ:GILD)has managed to lose about 40% of its value on the open market, and has vastly underperformed apassively held index fundover the same period (as shown below). As a market leader in the oncology, HIV, and hepatitis C drug markets, respectively, the company produces a suite of antivirals for typically hard-to-treat illnesses. While Gilead was -- and is -- front-and-center during the pandemic in its production of Veklury (more commonly known as remdesivir), it is not one of the major vaccine producers.</p><p>Perhaps the better news for those considering a Gilead investment is that the company is fundamentally quite strong. It trades at 9 times earnings, which is comparably cheap across the large-cap biotech sector. It projects a strong 2021, releasing guidance for revenue of $25 billion and EPS in the $7 range .</p><p>Put simply, the company trades at an attractive price relative to the earnings it generates, and the hope is that patients start treatment for other viral and chronic (non-COVID) illnesses now that the pandemic has waned a bit in the early part of the year.</p><p><img src=\"https://static.tigerbbs.com/3e7203dcf348bdd13924f561f04db9af\" tg-width=\"720\" tg-height=\"435\" referrerpolicy=\"no-referrer\"><b>DISH Network</b></p><p>Despite a stagnant stock price --<b>DISH Network</b>(NASDAQ:DISH)has fallen from just under $50 per share to around $35 today -- there is reason to believe a comeback is in the works. The stock currently trades at 11 times earnings, relatively cheap based on today's standards, and posted strong revenue growth in 2020, up about 40% from 2019.</p><p>DISH has engaged in a few creative partnerships; perhaps the most promising of the bunchis a pact with DraftKings, which seeks to offer sports betting from DISH set-top boxes. The underlying current here is that DISH Network has shown an ability to think outside the box, which is reflected in itsprofitability measures. It is a buy at its current price, and has an opportunity to stage a comeback in the coming years.</p><p><b>Tupperware Brands</b></p><p>While not the most high-flying name you've ever heard,<b>Tupperware Brands</b>(NYSE:TUP)simply runs a sustainably profitable business. Last year's earnings were $2.24 a share, and the stock currently trades around $25 per share, leading to a current price-to-earnings ratio of only about 11. While overall sales were down in 2020, profitable sales growth rose, a sign that the company is still able to control costs and make money in the most difficult of circumstances.</p><p>The stock has also lost two-thirds of its value since 2013 but remains profitable. According to its year-end press release, the company has been successful in restructuring its debt and executing on its turnaround plans (especially concerning its core businesses). Shares remain cheap for the moment, but the fact remains: The company makes money and has the financials to prove it.</p><p><b>When in doubt, seek value</b></p><p>The basic premise of value investing is to find profitable companies that happen to be on sale in the open market. While single-stock investing is far from a guaranteed strategy, it's worth looking into seemingly \"forgotten\" companies that simply have not yet had their day in the sun. Companies that have demonstrated their ability to grow and sustain profitability are your best bet, especially when they're cheap.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street Has Given Up on These 3 Stocks, and That's a Huge Mistake</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street Has Given Up on These 3 Stocks, and That's a Huge Mistake\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-02 20:16 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/02/wall-street-has-given-up-on-these-3-stocks-and-tha/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It's never a bad time to search for beaten-down stocks that are profitable on paper.Searching forvalue stocksis pretty simple: Find financially robust companies that have performed poorly from a share...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/02/wall-street-has-given-up-on-these-3-stocks-and-tha/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GILD":"吉利德科学","DISH":"Dish Network"},"source_url":"https://www.fool.com/investing/2021/04/02/wall-street-has-given-up-on-these-3-stocks-and-tha/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1121666420","content_text":"It's never a bad time to search for beaten-down stocks that are profitable on paper.Searching forvalue stocksis pretty simple: Find financially robust companies that have performed poorly from a share price perspective, and buy them when they're down. When the share price comes back to reality, you'll be a winner. Wall Street has the habit of kicking a stock when it's down, as negative sentiment surrounding a particular name can spell doom for shareholders.For those seeking value, these moments present an opportunity. Here, we'll look at three value stocks that have seen better days, but also have a good chance at rebounding.Gilead SciencesOver the past five years,Gilead Sciences(NASDAQ:GILD)has managed to lose about 40% of its value on the open market, and has vastly underperformed apassively held index fundover the same period (as shown below). As a market leader in the oncology, HIV, and hepatitis C drug markets, respectively, the company produces a suite of antivirals for typically hard-to-treat illnesses. While Gilead was -- and is -- front-and-center during the pandemic in its production of Veklury (more commonly known as remdesivir), it is not one of the major vaccine producers.Perhaps the better news for those considering a Gilead investment is that the company is fundamentally quite strong. It trades at 9 times earnings, which is comparably cheap across the large-cap biotech sector. It projects a strong 2021, releasing guidance for revenue of $25 billion and EPS in the $7 range .Put simply, the company trades at an attractive price relative to the earnings it generates, and the hope is that patients start treatment for other viral and chronic (non-COVID) illnesses now that the pandemic has waned a bit in the early part of the year.DISH NetworkDespite a stagnant stock price --DISH Network(NASDAQ:DISH)has fallen from just under $50 per share to around $35 today -- there is reason to believe a comeback is in the works. The stock currently trades at 11 times earnings, relatively cheap based on today's standards, and posted strong revenue growth in 2020, up about 40% from 2019.DISH has engaged in a few creative partnerships; perhaps the most promising of the bunchis a pact with DraftKings, which seeks to offer sports betting from DISH set-top boxes. The underlying current here is that DISH Network has shown an ability to think outside the box, which is reflected in itsprofitability measures. It is a buy at its current price, and has an opportunity to stage a comeback in the coming years.Tupperware BrandsWhile not the most high-flying name you've ever heard,Tupperware Brands(NYSE:TUP)simply runs a sustainably profitable business. Last year's earnings were $2.24 a share, and the stock currently trades around $25 per share, leading to a current price-to-earnings ratio of only about 11. While overall sales were down in 2020, profitable sales growth rose, a sign that the company is still able to control costs and make money in the most difficult of circumstances.The stock has also lost two-thirds of its value since 2013 but remains profitable. According to its year-end press release, the company has been successful in restructuring its debt and executing on its turnaround plans (especially concerning its core businesses). Shares remain cheap for the moment, but the fact remains: The company makes money and has the financials to prove it.When in doubt, seek valueThe basic premise of value investing is to find profitable companies that happen to be on sale in the open market. While single-stock investing is far from a guaranteed strategy, it's worth looking into seemingly \"forgotten\" companies that simply have not yet had their day in the sun. Companies that have demonstrated their ability to grow and sustain profitability are your best bet, especially when they're cheap.","news_type":1,"symbols_score_info":{"DISH":0.9,"GILD":0.9}},"isVote":1,"tweetType":1,"viewCount":1382,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":369506659,"gmtCreate":1614054584771,"gmtModify":1631886632803,"author":{"id":"3562381348726197","authorId":"3562381348726197","name":"Jasxcjm","avatar":"https://static.tigerbbs.com/30d8e49d33f2e14f0349d94e1a091311","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562381348726197","idStr":"3562381348726197"},"themes":[],"htmlText":"Buy more at trend reversal&nbsp;","listText":"Buy more at trend reversal&nbsp;","text":"Buy more at trend reversal","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/369506659","repostId":"1175731087","repostType":4,"repost":{"id":"1175731087","kind":"news","pubTimestamp":1614049350,"share":"https://www.laohu8.com/m/news/1175731087?lang=&edition=full","pubTime":"2021-02-23 11:02","market":"us","language":"en","title":"Tesla Stock Is in a Bear Market. It’s Taking Other EV Stocks With It.","url":"https://stock-news.laohu8.com/highlight/detail?id=1175731087","media":"Barrons","summary":"Stock in the electric- vehicle pioneer Tesla is now in bear-market territory. That’s a problem for the entire EV sector.Tesla shares closed down 8.6% Monday at $714.50 a share. That leaves them down almost $186 from the 52-week high of $900.40 they reached in January. That’s a drop of roughly 21%.Of course, Tesla is the 800-pound gorilla in the EV sector. It is worth almost as much as all other traditional car makers combined. And when Tesla stock drops, other EV stocks follow because Wall Stree","content":"<p>Stock in the electric- vehicle pioneer&nbsp;Tesla&nbsp;is now in&nbsp;bear-market&nbsp;territory. That’s a problem for the entire&nbsp;EV sector.</p><p>Tesla shares closed down 8.6% Monday at $714.50 a share. That leaves them down almost $186 from the 52-week high of $900.40 they reached in January. That’s a drop of roughly 21%.</p><p>It seems odd to say, given that the term is usually applied to broad groups of stocks, but there is a new bear market—a drop of 20% from a high—in Tesla shares.</p><p>Of course, Tesla is the&nbsp;800-pound gorilla&nbsp;in the EV sector. It is worth almost as much as all other traditional car makers combined. And when Tesla stock drops, other EV stocks follow because Wall Street often relies on Tesla’s valuation to come up with price targets.</p><p>Monday, shares of three other&nbsp;high-flying&nbsp;EV stocks with significant sales—NIO(NIO),XPeng(XPEV) andLi Auto(LI)—fell roughly 7% to 8%. And since Tesla stock hit its all-time high, NIO, XPeng and&nbsp;Li Auto&nbsp;shares are down roughly 20% on average, just like Tesla.</p><p>It looks as if Tesla is the benchmark for EV stocks just like the&nbsp;S&amp;P 500&nbsp;is the basis for comparison for U.S. stocks. That raises an interesting idea for EV investors: the Tesla version of beta. The beta concept can be thought of, in a sense, as a measure of a stock’s systemic risk. What happens to a market is linked to what happens to an individual stock by that stock’s beta.</p><p>If a stock, for instance, has a beta of 2, it would be expected to rise about 2% if the market rose 1%. Beta values aren’t always above 1. Gold-mining companies in theS&amp;P 500,for instance, have a beta of roughly 0.5, so they don’t rise as fast if the broader index goes up.</p><p>Investors can interpret the gold beta as saying roughly half of what happens to those golds stock is explained by what happens to the S&amp;P 500, and the other half is due to other factors, such as what’s going on with gold prices.</p><p>Beta is just a mathematical calculation. Investors, if they want, can calculate a stock’s beta relative to atmospheric pressure in Central Park. The math has to mean something, though, so no one does that. In the case of EVs, however, the idea of Tesla-as-risk to any EV stock doesn’t feel like a stretch.</p><p>The “Tesla beta” of the three Chinese EV stocks—NIO, XPeng and Li—is about 0.5. That can be interpreted, as with gold stocks, as saying about half of what happens to those three shares is a function of what happens to Tesla stock.</p><p>It’s an interesting idea. But what is happening to Tesla stock anyway?</p><p>It’s all about the potential for higher inflation. Increasing inflation, a growing concern in the market, tends to punish high-growth stocks more than low-growth stocks because of the way financial discount rates work. Most of Tesla’s cash flow comes in future years, and future cash flow is worth less today when interest rates rise.</p><p>Monday, many growth stocks took it on the chin. The&nbsp;Nasdaq Composite,known as the home of many fast-growing tech companies, fell 2.5%. Tesla’s beta value relative to the Nasdaq is about 2, so investors shouldn’t be surprised by a 5% drop in Tesla stock.</p><p>Tesla shares fell 9%, though. The extra 4% remains a mystery. The news site&nbsp;Electrek&nbsp;reported Tesla stopped taking orders for its lowest-priced Model Y, but high demand for lower-price EV models isn’t really a bad thing.</p><p><img src=\"https://static.tigerbbs.com/728e2afa9536498c3500bf3fdae26f29\" tg-width=\"642\" tg-height=\"213\" referrerpolicy=\"no-referrer\"></p><p>CEO&nbsp;Elon Musk&nbsp;is also spending a lot of time tweeting about&nbsp;cryptocurrencies. That might be unnerving Tesla investors. His tweeting, however, isn’t really any different than recent history. Musk is famous for his tweeting on lots of topics.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla Stock Is in a Bear Market. It’s Taking Other EV Stocks With It.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla Stock Is in a Bear Market. It’s Taking Other EV Stocks With It.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-23 11:02 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/tesla-stock-is-in-a-bear-market-its-taking-other-ev-stocks-with-it-51614034570?mod=hp_LEAD_3><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Stock in the electric- vehicle pioneer Tesla is now in bear-market territory. That’s a problem for the entire EV sector.Tesla shares closed down 8.6% Monday at $714.50 a share. That leaves them down ...</p>\n\n<a href=\"https://www.barrons.com/articles/tesla-stock-is-in-a-bear-market-its-taking-other-ev-stocks-with-it-51614034570?mod=hp_LEAD_3\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"XPEV":"小鹏汽车","LI":"理想汽车","TSLA":"特斯拉","NIO":"蔚来"},"source_url":"https://www.barrons.com/articles/tesla-stock-is-in-a-bear-market-its-taking-other-ev-stocks-with-it-51614034570?mod=hp_LEAD_3","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1175731087","content_text":"Stock in the electric- vehicle pioneer Tesla is now in bear-market territory. That’s a problem for the entire EV sector.Tesla shares closed down 8.6% Monday at $714.50 a share. That leaves them down almost $186 from the 52-week high of $900.40 they reached in January. That’s a drop of roughly 21%.It seems odd to say, given that the term is usually applied to broad groups of stocks, but there is a new bear market—a drop of 20% from a high—in Tesla shares.Of course, Tesla is the 800-pound gorilla in the EV sector. It is worth almost as much as all other traditional car makers combined. And when Tesla stock drops, other EV stocks follow because Wall Street often relies on Tesla’s valuation to come up with price targets.Monday, shares of three other high-flying EV stocks with significant sales—NIO(NIO),XPeng(XPEV) andLi Auto(LI)—fell roughly 7% to 8%. And since Tesla stock hit its all-time high, NIO, XPeng and Li Auto shares are down roughly 20% on average, just like Tesla.It looks as if Tesla is the benchmark for EV stocks just like the S&P 500 is the basis for comparison for U.S. stocks. That raises an interesting idea for EV investors: the Tesla version of beta. The beta concept can be thought of, in a sense, as a measure of a stock’s systemic risk. What happens to a market is linked to what happens to an individual stock by that stock’s beta.If a stock, for instance, has a beta of 2, it would be expected to rise about 2% if the market rose 1%. Beta values aren’t always above 1. Gold-mining companies in theS&P 500,for instance, have a beta of roughly 0.5, so they don’t rise as fast if the broader index goes up.Investors can interpret the gold beta as saying roughly half of what happens to those golds stock is explained by what happens to the S&P 500, and the other half is due to other factors, such as what’s going on with gold prices.Beta is just a mathematical calculation. Investors, if they want, can calculate a stock’s beta relative to atmospheric pressure in Central Park. The math has to mean something, though, so no one does that. In the case of EVs, however, the idea of Tesla-as-risk to any EV stock doesn’t feel like a stretch.The “Tesla beta” of the three Chinese EV stocks—NIO, XPeng and Li—is about 0.5. That can be interpreted, as with gold stocks, as saying about half of what happens to those three shares is a function of what happens to Tesla stock.It’s an interesting idea. But what is happening to Tesla stock anyway?It’s all about the potential for higher inflation. Increasing inflation, a growing concern in the market, tends to punish high-growth stocks more than low-growth stocks because of the way financial discount rates work. Most of Tesla’s cash flow comes in future years, and future cash flow is worth less today when interest rates rise.Monday, many growth stocks took it on the chin. The Nasdaq Composite,known as the home of many fast-growing tech companies, fell 2.5%. Tesla’s beta value relative to the Nasdaq is about 2, so investors shouldn’t be surprised by a 5% drop in Tesla stock.Tesla shares fell 9%, though. The extra 4% remains a mystery. The news site Electrek reported Tesla stopped taking orders for its lowest-priced Model Y, but high demand for lower-price EV models isn’t really a bad thing.CEO Elon Musk is also spending a lot of time tweeting about cryptocurrencies. That might be unnerving Tesla investors. His tweeting, however, isn’t really any different than recent history. Musk is famous for his tweeting on lots of topics.","news_type":1,"symbols_score_info":{"LI":0.9,"NIO":0.9,"TSLA":0.9,"XPEV":0.9}},"isVote":1,"tweetType":1,"viewCount":1227,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":312994824,"gmtCreate":1611986916768,"gmtModify":1703757309050,"author":{"id":"3562381348726197","authorId":"3562381348726197","name":"Jasxcjm","avatar":"https://static.tigerbbs.com/30d8e49d33f2e14f0349d94e1a091311","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562381348726197","idStr":"3562381348726197"},"themes":[],"htmlText":"[难过]&nbsp;[难过]&nbsp;[难过]&nbsp;","listText":"[难过]&nbsp;[难过]&nbsp;[难过]&nbsp;","text":"[难过] [难过] [难过]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/312994824","repostId":"2107443272","repostType":2,"isVote":1,"tweetType":1,"viewCount":1838,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":311564925,"gmtCreate":1611815659367,"gmtModify":1703754170927,"author":{"id":"3562381348726197","authorId":"3562381348726197","name":"Jasxcjm","avatar":"https://static.tigerbbs.com/30d8e49d33f2e14f0349d94e1a091311","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562381348726197","idStr":"3562381348726197"},"themes":[],"htmlText":"Apps&nbsp;","listText":"Apps&nbsp;","text":"Apps","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/311564925","repostId":"2106525374","repostType":2,"isVote":1,"tweetType":1,"viewCount":592,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":319148253,"gmtCreate":1611559769272,"gmtModify":1703750897510,"author":{"id":"3562381348726197","authorId":"3562381348726197","name":"Jasxcjm","avatar":"https://static.tigerbbs.com/30d8e49d33f2e14f0349d94e1a091311","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562381348726197","idStr":"3562381348726197"},"themes":[],"htmlText":"It’s time&nbsp;","listText":"It’s time&nbsp;","text":"It’s time","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/319148253","repostId":"2106841299","repostType":2,"repost":{"id":"2106841299","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1611555127,"share":"https://www.laohu8.com/m/news/2106841299?lang=&edition=full","pubTime":"2021-01-25 14:12","language":"en","title":"Australia shares end at 11-month high as country approves Pfizer vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2106841299","media":"Reuters","summary":"* Mining index rises on Fortescue, BHP, and Rio boost   * Trading volumes low ahead of holiday on Tu","content":"<html><body><p>* Mining index rises on Fortescue, BHP, and Rio boost</p><p>   * Trading volumes low ahead of holiday on Tuesday</p><p>   * NZ index closes 0.5% firmer, <a href=\"https://laohu8.com/S/OCA.AU\">Oceania Healthcare</a> top gainer</p><p> (Updates to close)</p><p>   By Harish Sridharan</p><p>   Jan 25 (Reuters) - Australian shares closed higher on Monday after the country's drug regulator approved the Pfizer-BioNTech COVID-19 vaccine for use, while expectations of a $1.9 trillion fiscal stimulus plan to kick-start the U.S economy lifted broader sentiment.</p><p>   Global equity markets have scaled record highs in recent days on bets COVID-19 vaccines will start to reduce the infection rates worldwide and on a stronger U.S. economic recovery under President Joe Biden.</p><p>   The S&amp;P/ASX 200 index    closed 0.4% firmer at its highest since Feb. 25, 2020, after ending 0.3% lower on Friday. Trading volumes remained at just little over half of the 30-day average.</p><p>   The country's medical regulator was <a href=\"https://laohu8.com/S/AONE\">one</a> of the first in the world to complete a comprehensive approval of the Pfizer-BioNTech vaccine, while Australian Health Minister Greg Hunt told reporters that vaccination of priority groups is expected to begin by February-end, at 80,000 doses per week.</p><p>    \"Volumes are low, and there isn't a lot of activity simply because it's Australia day on Tuesday,\" said Brad Smoling, Managing Director of Smoling Stockbroking. </p><p>   \"The market is taking some relief due to the low number of coronavirus cases and the highly acclaimed Pfizer vaccine that will be rolled out in Australia,\" he said. </p><p>   Markets will be closed on Tuesday on account of Australia Day.     </p><p>   Miners    rose nearly 1.1%, and were the biggest boosts to the index with mining giant Rio Tinto    gaining 2.1%,  while rival BHP    rose nearly 0.89%.</p><p>   Technology stocks    advanced 1.1%, with buy-now-pay-later heavyweight Afterpay    rising 1.4%. Aerial imagery services provider <a href=\"https://laohu8.com/S/NEA.AU\">Nearmap</a>    jumped 5.1% and data services company Appen    closed 2.8% firmer.</p><p>   Energy stocks were the biggest drags on the benchmark, down 1.2% to their lowest in nearly two weeks, as prices inched lower on concerns of tepid demand following a rise in U.S. crude inventories and fresh restrictions in China. </p><p>   Woodside Petroleum    and Santos    both shed more than 1%. </p><p>   New Zealand's benchmark S&amp;P/NZX 50 index    rose 0.5% to finish the session at 13,399.1 points. </p><p>   Residential aged-care services provider Oceania Healthcare</p><p>  and business mail services provider Freightways</p><p>  were the top gainers in the benchmark. </p><p> (Reporting by Harish Sridharan in Bengaluru, Editing by Sherry Jacob-Phillips)</p><p>((harish.sridharan@thomsonreuters.com))</p><p> ((For more information on DIARIES &amp; DATA:</p><p>U.S. earnings diary    </p><p>Wall Street Week Ahead     </p><p>Global Economy Week Ahead    ................................................................ For latest top breaking news across all markets            ))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Australia shares end at 11-month high as country approves Pfizer vaccine</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAustralia shares end at 11-month high as country approves Pfizer vaccine\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-01-25 14:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>* Mining index rises on Fortescue, BHP, and Rio boost</p><p>   * Trading volumes low ahead of holiday on Tuesday</p><p>   * NZ index closes 0.5% firmer, <a href=\"https://laohu8.com/S/OCA.AU\">Oceania Healthcare</a> top gainer</p><p> (Updates to close)</p><p>   By Harish Sridharan</p><p>   Jan 25 (Reuters) - Australian shares closed higher on Monday after the country's drug regulator approved the Pfizer-BioNTech COVID-19 vaccine for use, while expectations of a $1.9 trillion fiscal stimulus plan to kick-start the U.S economy lifted broader sentiment.</p><p>   Global equity markets have scaled record highs in recent days on bets COVID-19 vaccines will start to reduce the infection rates worldwide and on a stronger U.S. economic recovery under President Joe Biden.</p><p>   The S&amp;P/ASX 200 index    closed 0.4% firmer at its highest since Feb. 25, 2020, after ending 0.3% lower on Friday. Trading volumes remained at just little over half of the 30-day average.</p><p>   The country's medical regulator was <a href=\"https://laohu8.com/S/AONE\">one</a> of the first in the world to complete a comprehensive approval of the Pfizer-BioNTech vaccine, while Australian Health Minister Greg Hunt told reporters that vaccination of priority groups is expected to begin by February-end, at 80,000 doses per week.</p><p>    \"Volumes are low, and there isn't a lot of activity simply because it's Australia day on Tuesday,\" said Brad Smoling, Managing Director of Smoling Stockbroking. </p><p>   \"The market is taking some relief due to the low number of coronavirus cases and the highly acclaimed Pfizer vaccine that will be rolled out in Australia,\" he said. </p><p>   Markets will be closed on Tuesday on account of Australia Day.     </p><p>   Miners    rose nearly 1.1%, and were the biggest boosts to the index with mining giant Rio Tinto    gaining 2.1%,  while rival BHP    rose nearly 0.89%.</p><p>   Technology stocks    advanced 1.1%, with buy-now-pay-later heavyweight Afterpay    rising 1.4%. Aerial imagery services provider <a href=\"https://laohu8.com/S/NEA.AU\">Nearmap</a>    jumped 5.1% and data services company Appen    closed 2.8% firmer.</p><p>   Energy stocks were the biggest drags on the benchmark, down 1.2% to their lowest in nearly two weeks, as prices inched lower on concerns of tepid demand following a rise in U.S. crude inventories and fresh restrictions in China. </p><p>   Woodside Petroleum    and Santos    both shed more than 1%. </p><p>   New Zealand's benchmark S&amp;P/NZX 50 index    rose 0.5% to finish the session at 13,399.1 points. </p><p>   Residential aged-care services provider Oceania Healthcare</p><p>  and business mail services provider Freightways</p><p>  were the top gainers in the benchmark. </p><p> (Reporting by Harish Sridharan in Bengaluru, Editing by Sherry Jacob-Phillips)</p><p>((harish.sridharan@thomsonreuters.com))</p><p> ((For more information on DIARIES &amp; DATA:</p><p>U.S. earnings diary    </p><p>Wall Street Week Ahead     </p><p>Global Economy Week Ahead    ................................................................ For latest top breaking news across all markets            ))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2106841299","content_text":"* Mining index rises on Fortescue, BHP, and Rio boost   * Trading volumes low ahead of holiday on Tuesday   * NZ index closes 0.5% firmer, Oceania Healthcare top gainer (Updates to close)   By Harish Sridharan   Jan 25 (Reuters) - Australian shares closed higher on Monday after the country's drug regulator approved the Pfizer-BioNTech COVID-19 vaccine for use, while expectations of a $1.9 trillion fiscal stimulus plan to kick-start the U.S economy lifted broader sentiment.   Global equity markets have scaled record highs in recent days on bets COVID-19 vaccines will start to reduce the infection rates worldwide and on a stronger U.S. economic recovery under President Joe Biden.   The S&P/ASX 200 index    closed 0.4% firmer at its highest since Feb. 25, 2020, after ending 0.3% lower on Friday. Trading volumes remained at just little over half of the 30-day average.   The country's medical regulator was one of the first in the world to complete a comprehensive approval of the Pfizer-BioNTech vaccine, while Australian Health Minister Greg Hunt told reporters that vaccination of priority groups is expected to begin by February-end, at 80,000 doses per week.    \"Volumes are low, and there isn't a lot of activity simply because it's Australia day on Tuesday,\" said Brad Smoling, Managing Director of Smoling Stockbroking.    \"The market is taking some relief due to the low number of coronavirus cases and the highly acclaimed Pfizer vaccine that will be rolled out in Australia,\" he said.    Markets will be closed on Tuesday on account of Australia Day.        Miners    rose nearly 1.1%, and were the biggest boosts to the index with mining giant Rio Tinto    gaining 2.1%,  while rival BHP    rose nearly 0.89%.   Technology stocks    advanced 1.1%, with buy-now-pay-later heavyweight Afterpay    rising 1.4%. Aerial imagery services provider Nearmap    jumped 5.1% and data services company Appen    closed 2.8% firmer.   Energy stocks were the biggest drags on the benchmark, down 1.2% to their lowest in nearly two weeks, as prices inched lower on concerns of tepid demand following a rise in U.S. crude inventories and fresh restrictions in China.    Woodside Petroleum    and Santos    both shed more than 1%.    New Zealand's benchmark S&P/NZX 50 index    rose 0.5% to finish the session at 13,399.1 points.    Residential aged-care services provider Oceania Healthcare  and business mail services provider Freightways  were the top gainers in the benchmark.  (Reporting by Harish Sridharan in Bengaluru, Editing by Sherry Jacob-Phillips)((harish.sridharan@thomsonreuters.com)) ((For more information on DIARIES & DATA:U.S. earnings diary    Wall Street Week Ahead     Global Economy Week Ahead    ................................................................ For latest top breaking news across all markets            ))","news_type":1,"symbols_score_info":{"PFE":1}},"isVote":1,"tweetType":1,"viewCount":524,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":310214589,"gmtCreate":1611328938641,"gmtModify":1703749845692,"author":{"id":"3562381348726197","authorId":"3562381348726197","name":"Jasxcjm","avatar":"https://static.tigerbbs.com/30d8e49d33f2e14f0349d94e1a091311","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562381348726197","idStr":"3562381348726197"},"themes":[],"htmlText":"Oh no&nbsp;","listText":"Oh no&nbsp;","text":"Oh no","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/310214589","repostId":"1106179554","repostType":4,"isVote":1,"tweetType":1,"viewCount":638,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3527667803686145","authorId":"3527667803686145","name":"社区成长助手","avatar":"https://static.tigerbbs.com/2b7c7106b5c0c8b0037faa67439d898f","crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3527667803686145","idStr":"3527667803686145"},"content":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题，可以获得更多曝光哦～如果您想创作优质文章，请查看老虎社区创作指引","text":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题，可以获得更多曝光哦～如果您想创作优质文章，请查看老虎社区创作指引","html":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题，可以获得更多曝光哦～如果您想创作优质文章，请查看老虎社区创作指引"}],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":167811362,"gmtCreate":1624257911556,"gmtModify":1631886632768,"author":{"id":"3562381348726197","authorId":"3562381348726197","name":"Jasxcjm","avatar":"https://static.tigerbbs.com/30d8e49d33f2e14f0349d94e1a091311","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562381348726197","authorIdStr":"3562381348726197"},"themes":[],"htmlText":"Like and comment pls? :)&nbsp;","listText":"Like and comment pls? :)&nbsp;","text":"Like and comment pls? :)","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/167811362","repostId":"1154249454","repostType":4,"isVote":1,"tweetType":1,"viewCount":2078,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":124312824,"gmtCreate":1624736715668,"gmtModify":1631886632729,"author":{"id":"3562381348726197","authorId":"3562381348726197","name":"Jasxcjm","avatar":"https://static.tigerbbs.com/30d8e49d33f2e14f0349d94e1a091311","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562381348726197","authorIdStr":"3562381348726197"},"themes":[],"htmlText":"Hehe baidu&nbsp;","listText":"Hehe baidu&nbsp;","text":"Hehe baidu","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/124312824","repostId":"1164137597","repostType":4,"isVote":1,"tweetType":1,"viewCount":2458,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":164241327,"gmtCreate":1624214414669,"gmtModify":1631886632779,"author":{"id":"3562381348726197","authorId":"3562381348726197","name":"Jasxcjm","avatar":"https://static.tigerbbs.com/30d8e49d33f2e14f0349d94e1a091311","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562381348726197","authorIdStr":"3562381348726197"},"themes":[],"htmlText":"Hi pls like and comment!&nbsp;","listText":"Hi pls like and comment!&nbsp;","text":"Hi pls like and comment!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/164241327","repostId":"1199331995","repostType":4,"isVote":1,"tweetType":1,"viewCount":2178,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":126090610,"gmtCreate":1624535869630,"gmtModify":1631886632742,"author":{"id":"3562381348726197","authorId":"3562381348726197","name":"Jasxcjm","avatar":"https://static.tigerbbs.com/30d8e49d33f2e14f0349d94e1a091311","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562381348726197","authorIdStr":"3562381348726197"},"themes":[],"htmlText":"Damn son&nbsp;","listText":"Damn son&nbsp;","text":"Damn son","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/126090610","repostId":"1113369372","repostType":4,"repost":{"id":"1113369372","kind":"news","pubTimestamp":1624535308,"share":"https://www.laohu8.com/m/news/1113369372?lang=&edition=full","pubTime":"2021-06-24 19:48","market":"us","language":"en","title":"Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1113369372","media":"The Wall Street Journal","summary":"(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after th","content":"<p><i><b>(Update: June 24, 2021 at 09:32 a.m. ET)</b></i></p>\n<p>Eli Lilly shares jumped over 8% in&nbsp;morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.</p>\n<p><img src=\"https://static.tigerbbs.com/9b4cea69bed4d928fd18195924788827\" tg-width=\"658\" tg-height=\"438\"></p>\n<p>The move is meant to expedite the development and review of the experimental treatment.</p>\n<p>Rival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 19:48 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from ...</p>\n\n<a href=\"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LLY":"礼来"},"source_url":"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1113369372","content_text":"(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.\n\nThe move is meant to expedite the development and review of the experimental treatment.\nRival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.","news_type":1,"symbols_score_info":{"LLY":0.9}},"isVote":1,"tweetType":1,"viewCount":1359,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":340177912,"gmtCreate":1617366112936,"gmtModify":1631886632793,"author":{"id":"3562381348726197","authorId":"3562381348726197","name":"Jasxcjm","avatar":"https://static.tigerbbs.com/30d8e49d33f2e14f0349d94e1a091311","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562381348726197","authorIdStr":"3562381348726197"},"themes":[],"htmlText":"Haha","listText":"Haha","text":"Haha","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/340177912","repostId":"1121666420","repostType":4,"repost":{"id":"1121666420","kind":"news","pubTimestamp":1617365764,"share":"https://www.laohu8.com/m/news/1121666420?lang=&edition=full","pubTime":"2021-04-02 20:16","market":"us","language":"en","title":"Wall Street Has Given Up on These 3 Stocks, and That's a Huge Mistake","url":"https://stock-news.laohu8.com/highlight/detail?id=1121666420","media":"Motley Fool","summary":"It's never a bad time to search for beaten-down stocks that are profitable on paper.Searching forval","content":"<blockquote>It's never a bad time to search for beaten-down stocks that are profitable on paper.</blockquote><p>Searching forvalue stocksis pretty simple: Find financially robust companies that have performed poorly from a share price perspective, and buy them when they're down. When the share price comes back to reality, you'll be a winner. Wall Street has the habit of kicking a stock when it's down, as negative sentiment surrounding a particular name can spell doom for shareholders.</p><p>For those seeking value, these moments present an opportunity. Here, we'll look at three value stocks that have seen better days, but also have a good chance at rebounding.</p><p><b>Gilead Sciences</b></p><p>Over the past five years,<b>Gilead Sciences</b>(NASDAQ:GILD)has managed to lose about 40% of its value on the open market, and has vastly underperformed apassively held index fundover the same period (as shown below). As a market leader in the oncology, HIV, and hepatitis C drug markets, respectively, the company produces a suite of antivirals for typically hard-to-treat illnesses. While Gilead was -- and is -- front-and-center during the pandemic in its production of Veklury (more commonly known as remdesivir), it is not one of the major vaccine producers.</p><p>Perhaps the better news for those considering a Gilead investment is that the company is fundamentally quite strong. It trades at 9 times earnings, which is comparably cheap across the large-cap biotech sector. It projects a strong 2021, releasing guidance for revenue of $25 billion and EPS in the $7 range .</p><p>Put simply, the company trades at an attractive price relative to the earnings it generates, and the hope is that patients start treatment for other viral and chronic (non-COVID) illnesses now that the pandemic has waned a bit in the early part of the year.</p><p><img src=\"https://static.tigerbbs.com/3e7203dcf348bdd13924f561f04db9af\" tg-width=\"720\" tg-height=\"435\" referrerpolicy=\"no-referrer\"><b>DISH Network</b></p><p>Despite a stagnant stock price --<b>DISH Network</b>(NASDAQ:DISH)has fallen from just under $50 per share to around $35 today -- there is reason to believe a comeback is in the works. The stock currently trades at 11 times earnings, relatively cheap based on today's standards, and posted strong revenue growth in 2020, up about 40% from 2019.</p><p>DISH has engaged in a few creative partnerships; perhaps the most promising of the bunchis a pact with DraftKings, which seeks to offer sports betting from DISH set-top boxes. The underlying current here is that DISH Network has shown an ability to think outside the box, which is reflected in itsprofitability measures. It is a buy at its current price, and has an opportunity to stage a comeback in the coming years.</p><p><b>Tupperware Brands</b></p><p>While not the most high-flying name you've ever heard,<b>Tupperware Brands</b>(NYSE:TUP)simply runs a sustainably profitable business. Last year's earnings were $2.24 a share, and the stock currently trades around $25 per share, leading to a current price-to-earnings ratio of only about 11. While overall sales were down in 2020, profitable sales growth rose, a sign that the company is still able to control costs and make money in the most difficult of circumstances.</p><p>The stock has also lost two-thirds of its value since 2013 but remains profitable. According to its year-end press release, the company has been successful in restructuring its debt and executing on its turnaround plans (especially concerning its core businesses). Shares remain cheap for the moment, but the fact remains: The company makes money and has the financials to prove it.</p><p><b>When in doubt, seek value</b></p><p>The basic premise of value investing is to find profitable companies that happen to be on sale in the open market. While single-stock investing is far from a guaranteed strategy, it's worth looking into seemingly \"forgotten\" companies that simply have not yet had their day in the sun. Companies that have demonstrated their ability to grow and sustain profitability are your best bet, especially when they're cheap.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street Has Given Up on These 3 Stocks, and That's a Huge Mistake</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street Has Given Up on These 3 Stocks, and That's a Huge Mistake\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-02 20:16 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/02/wall-street-has-given-up-on-these-3-stocks-and-tha/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It's never a bad time to search for beaten-down stocks that are profitable on paper.Searching forvalue stocksis pretty simple: Find financially robust companies that have performed poorly from a share...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/02/wall-street-has-given-up-on-these-3-stocks-and-tha/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GILD":"吉利德科学","DISH":"Dish Network"},"source_url":"https://www.fool.com/investing/2021/04/02/wall-street-has-given-up-on-these-3-stocks-and-tha/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1121666420","content_text":"It's never a bad time to search for beaten-down stocks that are profitable on paper.Searching forvalue stocksis pretty simple: Find financially robust companies that have performed poorly from a share price perspective, and buy them when they're down. When the share price comes back to reality, you'll be a winner. Wall Street has the habit of kicking a stock when it's down, as negative sentiment surrounding a particular name can spell doom for shareholders.For those seeking value, these moments present an opportunity. Here, we'll look at three value stocks that have seen better days, but also have a good chance at rebounding.Gilead SciencesOver the past five years,Gilead Sciences(NASDAQ:GILD)has managed to lose about 40% of its value on the open market, and has vastly underperformed apassively held index fundover the same period (as shown below). As a market leader in the oncology, HIV, and hepatitis C drug markets, respectively, the company produces a suite of antivirals for typically hard-to-treat illnesses. While Gilead was -- and is -- front-and-center during the pandemic in its production of Veklury (more commonly known as remdesivir), it is not one of the major vaccine producers.Perhaps the better news for those considering a Gilead investment is that the company is fundamentally quite strong. It trades at 9 times earnings, which is comparably cheap across the large-cap biotech sector. It projects a strong 2021, releasing guidance for revenue of $25 billion and EPS in the $7 range .Put simply, the company trades at an attractive price relative to the earnings it generates, and the hope is that patients start treatment for other viral and chronic (non-COVID) illnesses now that the pandemic has waned a bit in the early part of the year.DISH NetworkDespite a stagnant stock price --DISH Network(NASDAQ:DISH)has fallen from just under $50 per share to around $35 today -- there is reason to believe a comeback is in the works. The stock currently trades at 11 times earnings, relatively cheap based on today's standards, and posted strong revenue growth in 2020, up about 40% from 2019.DISH has engaged in a few creative partnerships; perhaps the most promising of the bunchis a pact with DraftKings, which seeks to offer sports betting from DISH set-top boxes. The underlying current here is that DISH Network has shown an ability to think outside the box, which is reflected in itsprofitability measures. It is a buy at its current price, and has an opportunity to stage a comeback in the coming years.Tupperware BrandsWhile not the most high-flying name you've ever heard,Tupperware Brands(NYSE:TUP)simply runs a sustainably profitable business. Last year's earnings were $2.24 a share, and the stock currently trades around $25 per share, leading to a current price-to-earnings ratio of only about 11. While overall sales were down in 2020, profitable sales growth rose, a sign that the company is still able to control costs and make money in the most difficult of circumstances.The stock has also lost two-thirds of its value since 2013 but remains profitable. According to its year-end press release, the company has been successful in restructuring its debt and executing on its turnaround plans (especially concerning its core businesses). Shares remain cheap for the moment, but the fact remains: The company makes money and has the financials to prove it.When in doubt, seek valueThe basic premise of value investing is to find profitable companies that happen to be on sale in the open market. While single-stock investing is far from a guaranteed strategy, it's worth looking into seemingly \"forgotten\" companies that simply have not yet had their day in the sun. Companies that have demonstrated their ability to grow and sustain profitability are your best bet, especially when they're cheap.","news_type":1,"symbols_score_info":{"DISH":0.9,"GILD":0.9}},"isVote":1,"tweetType":1,"viewCount":1382,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":369506659,"gmtCreate":1614054584771,"gmtModify":1631886632803,"author":{"id":"3562381348726197","authorId":"3562381348726197","name":"Jasxcjm","avatar":"https://static.tigerbbs.com/30d8e49d33f2e14f0349d94e1a091311","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562381348726197","authorIdStr":"3562381348726197"},"themes":[],"htmlText":"Buy more at trend reversal&nbsp;","listText":"Buy more at trend reversal&nbsp;","text":"Buy more at trend reversal","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/369506659","repostId":"1175731087","repostType":4,"repost":{"id":"1175731087","kind":"news","pubTimestamp":1614049350,"share":"https://www.laohu8.com/m/news/1175731087?lang=&edition=full","pubTime":"2021-02-23 11:02","market":"us","language":"en","title":"Tesla Stock Is in a Bear Market. It’s Taking Other EV Stocks With It.","url":"https://stock-news.laohu8.com/highlight/detail?id=1175731087","media":"Barrons","summary":"Stock in the electric- vehicle pioneer Tesla is now in bear-market territory. That’s a problem for the entire EV sector.Tesla shares closed down 8.6% Monday at $714.50 a share. That leaves them down almost $186 from the 52-week high of $900.40 they reached in January. That’s a drop of roughly 21%.Of course, Tesla is the 800-pound gorilla in the EV sector. It is worth almost as much as all other traditional car makers combined. And when Tesla stock drops, other EV stocks follow because Wall Stree","content":"<p>Stock in the electric- vehicle pioneer&nbsp;Tesla&nbsp;is now in&nbsp;bear-market&nbsp;territory. That’s a problem for the entire&nbsp;EV sector.</p><p>Tesla shares closed down 8.6% Monday at $714.50 a share. That leaves them down almost $186 from the 52-week high of $900.40 they reached in January. That’s a drop of roughly 21%.</p><p>It seems odd to say, given that the term is usually applied to broad groups of stocks, but there is a new bear market—a drop of 20% from a high—in Tesla shares.</p><p>Of course, Tesla is the&nbsp;800-pound gorilla&nbsp;in the EV sector. It is worth almost as much as all other traditional car makers combined. And when Tesla stock drops, other EV stocks follow because Wall Street often relies on Tesla’s valuation to come up with price targets.</p><p>Monday, shares of three other&nbsp;high-flying&nbsp;EV stocks with significant sales—NIO(NIO),XPeng(XPEV) andLi Auto(LI)—fell roughly 7% to 8%. And since Tesla stock hit its all-time high, NIO, XPeng and&nbsp;Li Auto&nbsp;shares are down roughly 20% on average, just like Tesla.</p><p>It looks as if Tesla is the benchmark for EV stocks just like the&nbsp;S&amp;P 500&nbsp;is the basis for comparison for U.S. stocks. That raises an interesting idea for EV investors: the Tesla version of beta. The beta concept can be thought of, in a sense, as a measure of a stock’s systemic risk. What happens to a market is linked to what happens to an individual stock by that stock’s beta.</p><p>If a stock, for instance, has a beta of 2, it would be expected to rise about 2% if the market rose 1%. Beta values aren’t always above 1. Gold-mining companies in theS&amp;P 500,for instance, have a beta of roughly 0.5, so they don’t rise as fast if the broader index goes up.</p><p>Investors can interpret the gold beta as saying roughly half of what happens to those golds stock is explained by what happens to the S&amp;P 500, and the other half is due to other factors, such as what’s going on with gold prices.</p><p>Beta is just a mathematical calculation. Investors, if they want, can calculate a stock’s beta relative to atmospheric pressure in Central Park. The math has to mean something, though, so no one does that. In the case of EVs, however, the idea of Tesla-as-risk to any EV stock doesn’t feel like a stretch.</p><p>The “Tesla beta” of the three Chinese EV stocks—NIO, XPeng and Li—is about 0.5. That can be interpreted, as with gold stocks, as saying about half of what happens to those three shares is a function of what happens to Tesla stock.</p><p>It’s an interesting idea. But what is happening to Tesla stock anyway?</p><p>It’s all about the potential for higher inflation. Increasing inflation, a growing concern in the market, tends to punish high-growth stocks more than low-growth stocks because of the way financial discount rates work. Most of Tesla’s cash flow comes in future years, and future cash flow is worth less today when interest rates rise.</p><p>Monday, many growth stocks took it on the chin. The&nbsp;Nasdaq Composite,known as the home of many fast-growing tech companies, fell 2.5%. Tesla’s beta value relative to the Nasdaq is about 2, so investors shouldn’t be surprised by a 5% drop in Tesla stock.</p><p>Tesla shares fell 9%, though. The extra 4% remains a mystery. The news site&nbsp;Electrek&nbsp;reported Tesla stopped taking orders for its lowest-priced Model Y, but high demand for lower-price EV models isn’t really a bad thing.</p><p><img src=\"https://static.tigerbbs.com/728e2afa9536498c3500bf3fdae26f29\" tg-width=\"642\" tg-height=\"213\" referrerpolicy=\"no-referrer\"></p><p>CEO&nbsp;Elon Musk&nbsp;is also spending a lot of time tweeting about&nbsp;cryptocurrencies. That might be unnerving Tesla investors. His tweeting, however, isn’t really any different than recent history. Musk is famous for his tweeting on lots of topics.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla Stock Is in a Bear Market. It’s Taking Other EV Stocks With It.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla Stock Is in a Bear Market. It’s Taking Other EV Stocks With It.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-23 11:02 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/tesla-stock-is-in-a-bear-market-its-taking-other-ev-stocks-with-it-51614034570?mod=hp_LEAD_3><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Stock in the electric- vehicle pioneer Tesla is now in bear-market territory. That’s a problem for the entire EV sector.Tesla shares closed down 8.6% Monday at $714.50 a share. That leaves them down ...</p>\n\n<a href=\"https://www.barrons.com/articles/tesla-stock-is-in-a-bear-market-its-taking-other-ev-stocks-with-it-51614034570?mod=hp_LEAD_3\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"XPEV":"小鹏汽车","LI":"理想汽车","TSLA":"特斯拉","NIO":"蔚来"},"source_url":"https://www.barrons.com/articles/tesla-stock-is-in-a-bear-market-its-taking-other-ev-stocks-with-it-51614034570?mod=hp_LEAD_3","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1175731087","content_text":"Stock in the electric- vehicle pioneer Tesla is now in bear-market territory. That’s a problem for the entire EV sector.Tesla shares closed down 8.6% Monday at $714.50 a share. That leaves them down almost $186 from the 52-week high of $900.40 they reached in January. That’s a drop of roughly 21%.It seems odd to say, given that the term is usually applied to broad groups of stocks, but there is a new bear market—a drop of 20% from a high—in Tesla shares.Of course, Tesla is the 800-pound gorilla in the EV sector. It is worth almost as much as all other traditional car makers combined. And when Tesla stock drops, other EV stocks follow because Wall Street often relies on Tesla’s valuation to come up with price targets.Monday, shares of three other high-flying EV stocks with significant sales—NIO(NIO),XPeng(XPEV) andLi Auto(LI)—fell roughly 7% to 8%. And since Tesla stock hit its all-time high, NIO, XPeng and Li Auto shares are down roughly 20% on average, just like Tesla.It looks as if Tesla is the benchmark for EV stocks just like the S&P 500 is the basis for comparison for U.S. stocks. That raises an interesting idea for EV investors: the Tesla version of beta. The beta concept can be thought of, in a sense, as a measure of a stock’s systemic risk. What happens to a market is linked to what happens to an individual stock by that stock’s beta.If a stock, for instance, has a beta of 2, it would be expected to rise about 2% if the market rose 1%. Beta values aren’t always above 1. Gold-mining companies in theS&P 500,for instance, have a beta of roughly 0.5, so they don’t rise as fast if the broader index goes up.Investors can interpret the gold beta as saying roughly half of what happens to those golds stock is explained by what happens to the S&P 500, and the other half is due to other factors, such as what’s going on with gold prices.Beta is just a mathematical calculation. Investors, if they want, can calculate a stock’s beta relative to atmospheric pressure in Central Park. The math has to mean something, though, so no one does that. In the case of EVs, however, the idea of Tesla-as-risk to any EV stock doesn’t feel like a stretch.The “Tesla beta” of the three Chinese EV stocks—NIO, XPeng and Li—is about 0.5. That can be interpreted, as with gold stocks, as saying about half of what happens to those three shares is a function of what happens to Tesla stock.It’s an interesting idea. But what is happening to Tesla stock anyway?It’s all about the potential for higher inflation. Increasing inflation, a growing concern in the market, tends to punish high-growth stocks more than low-growth stocks because of the way financial discount rates work. Most of Tesla’s cash flow comes in future years, and future cash flow is worth less today when interest rates rise.Monday, many growth stocks took it on the chin. The Nasdaq Composite,known as the home of many fast-growing tech companies, fell 2.5%. Tesla’s beta value relative to the Nasdaq is about 2, so investors shouldn’t be surprised by a 5% drop in Tesla stock.Tesla shares fell 9%, though. The extra 4% remains a mystery. The news site Electrek reported Tesla stopped taking orders for its lowest-priced Model Y, but high demand for lower-price EV models isn’t really a bad thing.CEO Elon Musk is also spending a lot of time tweeting about cryptocurrencies. That might be unnerving Tesla investors. His tweeting, however, isn’t really any different than recent history. Musk is famous for his tweeting on lots of topics.","news_type":1,"symbols_score_info":{"LI":0.9,"NIO":0.9,"TSLA":0.9,"XPEV":0.9}},"isVote":1,"tweetType":1,"viewCount":1227,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":699511362,"gmtCreate":1639837416665,"gmtModify":1639837416800,"author":{"id":"3562381348726197","authorId":"3562381348726197","name":"Jasxcjm","avatar":"https://static.tigerbbs.com/30d8e49d33f2e14f0349d94e1a091311","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562381348726197","authorIdStr":"3562381348726197"},"themes":[],"htmlText":"Target (TGT) - The stock price of TGT does not justify the judgmentals.&nbsp;","listText":"Target (TGT) - The stock price of TGT does not justify the judgmentals.&nbsp;","text":"Target (TGT) - The stock price of TGT does not justify the judgmentals.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/699511362","isVote":1,"tweetType":1,"viewCount":1463,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":310214589,"gmtCreate":1611328938641,"gmtModify":1703749845692,"author":{"id":"3562381348726197","authorId":"3562381348726197","name":"Jasxcjm","avatar":"https://static.tigerbbs.com/30d8e49d33f2e14f0349d94e1a091311","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562381348726197","authorIdStr":"3562381348726197"},"themes":[],"htmlText":"Oh no&nbsp;","listText":"Oh no&nbsp;","text":"Oh no","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/310214589","repostId":"1106179554","repostType":4,"isVote":1,"tweetType":1,"viewCount":638,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3527667803686145","authorId":"3527667803686145","name":"社区成长助手","avatar":"https://static.tigerbbs.com/2b7c7106b5c0c8b0037faa67439d898f","crmLevel":1,"crmLevelSwitch":0,"idStr":"3527667803686145","authorIdStr":"3527667803686145"},"content":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题，可以获得更多曝光哦～如果您想创作优质文章，请查看老虎社区创作指引","text":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题，可以获得更多曝光哦～如果您想创作优质文章，请查看老虎社区创作指引","html":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题，可以获得更多曝光哦～如果您想创作优质文章，请查看老虎社区创作指引"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":690721649,"gmtCreate":1639710812581,"gmtModify":1639710812707,"author":{"id":"3562381348726197","authorId":"3562381348726197","name":"Jasxcjm","avatar":"https://static.tigerbbs.com/30d8e49d33f2e14f0349d94e1a091311","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562381348726197","authorIdStr":"3562381348726197"},"themes":[],"htmlText":"Hmmm&nbsp;","listText":"Hmmm&nbsp;","text":"Hmmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690721649","isVote":1,"tweetType":1,"viewCount":2485,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":126090081,"gmtCreate":1624535844543,"gmtModify":1631886632755,"author":{"id":"3562381348726197","authorId":"3562381348726197","name":"Jasxcjm","avatar":"https://static.tigerbbs.com/30d8e49d33f2e14f0349d94e1a091311","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562381348726197","authorIdStr":"3562381348726197"},"themes":[],"htmlText":"Yes","listText":"Yes","text":"Yes","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/126090081","repostId":"1191442444","repostType":4,"repost":{"id":"1191442444","kind":"news","pubTimestamp":1624534197,"share":"https://www.laohu8.com/m/news/1191442444?lang=&edition=full","pubTime":"2021-06-24 19:29","market":"uk","language":"en","title":"BoE Keeps Rates, QE Unchanged; Won't Tighten Until \"Clear Evidence Of Progress\" Toward Inflation Goal","url":"https://stock-news.laohu8.com/highlight/detail?id=1191442444","media":"zerohedge","summary":"With central banks riding a hawkish wave in recent months, eyes turned toward the Bank of England an","content":"<p>With central banks riding a hawkish wave in recent months, eyes turned toward the Bank of England and its latest monetary policy decision this morning, which however did not surprise as the central bank voted unanimously to keep interest rates at 0.1% and by a majority of 8-1 to maintain the amount of quantitative easing at £895bn, with outgoing chief economist Haldane again dissenting and voting to reduce the asset purchase target in his final vote before leaving the Bank of England.</p>\n<p><img src=\"https://static.tigerbbs.com/ee2372b645665ef729732f7accedac5e\" tg-width=\"510\" tg-height=\"538\"></p>\n<p>So with inflation surging in the UK as everywhere else, how did the BOE deflect calls to tighten? Simple, like the Fed it said that while inflation may rise above 3%, it will be transitory, to wit: \"<i>CPI inflation is expected to pick up further above the target, owing primarily to developments in energy and other commodity prices,</i><i><b>and is likely to exceed 3% for a temporary period</b></i><i>\"</i>which means June output is expected to be around 2.5% below its pre-Covid level in the final quarter of 2019. For context, the previous inflation peak was projected to be 2.5%, so yet another significant reflationary rethink.</p>\n<p>And once said \"temporary period\" ends, all shall be well, however nobody knows when that will be, just as nobody knows what the<b>\"clear evidence of significant progress\"</b>toward achieving the 2% inflation target is that the BOE needs before tightening policy.</p>\n<p>And while the BOE won't issue a fresh round of forecasts until August, they did revise up their second-quarter projection by around 1.5 percentage points from their May projection of 4.3%.</p>\n<p>Some more details from thefull statement:</p>\n<ul>\n <li>Committee’s expectation is that the direct impact of rises in commodity prices on CPI inflation will be transitory.</li>\n <li>Output in a number of sectors is now around pre-Covid levels, although it remains materially below in others</li>\n <li>Developments in global GDP growth have been somewhat stronger than anticipated, particularly in advanced economies</li>\n <li>The Committee does not intend to tighten monetary policy at least until there is clear evidence that significant progress is being made in eliminating spare capacity and achieving the 2% inflation target sustainably.</li>\n <li>Spare capacity in the economy was expected to be eliminated as activity picked up, and there was expected to be a temporary period of excess demand, before demand and supply returned broadly to balance.</li>\n <li>Policy should both lean strongly against downside risks to the outlook and ensure that the recovery was not undermined by a premature tightening in monetary conditions.</li>\n <li>Most members judged that the conditions set out in the MPC’s existing policy guidance, which were in any case necessary but not sufficient conditions for any future tightening in monetary policy, were not met.</li>\n <li>Bank staff had revised up their expectations for 2021 Q2 GDP growth to 5.5%, from 4.25% at the&nbsp; time of the May Report. That would be consistent with output in Q2 being less than 4% below its 2019 Q4 level, and projected output in June around 2.5% lower.</li>\n <li>It was possible that a stronger path for demand would close the output gap somewhat sooner than had previously been expected.</li>\n</ul>\n<p>The market response was muted as the decision appeared to come on the dovish side: the pound reversed modest gains as short-term positioning over a hawkish surprise is unwound. Gilts rise, with 10-year yield down by 3 basis points to 0.75%.</p>\n<p><img src=\"https://static.tigerbbs.com/7010feb093662e50703d0e073ffbf258\" tg-width=\"500\" tg-height=\"242\"></p>\n<p>According to Bloomberg, in the longer term, and until a shift comes, the pound may stay under pressure especially as it trades below its 21-weekly moving average, a momentum-defining indicator since the pandemic started.</p>\n<p>At the same time, EUR/GBP rallied as stops were triggered given the transitory-inflation narrative remains and cable dips toward the $1.39 handle. According to Bloomberg,<b>a 15bps rate hike by the BOE is now pushed back to Aug 2022 from June 2022 just before the decision.</b>It remains to be seen whether this is more interest to trade the pound afresh or is it all down to short-term position rebalancing.</p>\n<p>Bottom line: today's somewhat dovish statements puts a lot of attention on to the August meeting when we’ll get a full set of new forecasts and learn more about the BOE's thinking; we should also have a clearer sense of how the virus situation is developing once more people are vaccinated.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BoE Keeps Rates, QE Unchanged; Won't Tighten Until \"Clear Evidence Of Progress\" Toward Inflation Goal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBoE Keeps Rates, QE Unchanged; Won't Tighten Until \"Clear Evidence Of Progress\" Toward Inflation Goal\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 19:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.zerohedge.com/markets/boe-keeps-rates-qe-unchanged-wont-tighten-until-clear-evidence-progress-toward-inflation><strong>zerohedge</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>With central banks riding a hawkish wave in recent months, eyes turned toward the Bank of England and its latest monetary policy decision this morning, which however did not surprise as the central ...</p>\n\n<a href=\"https://www.zerohedge.com/markets/boe-keeps-rates-qe-unchanged-wont-tighten-until-clear-evidence-progress-toward-inflation\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.zerohedge.com/markets/boe-keeps-rates-qe-unchanged-wont-tighten-until-clear-evidence-progress-toward-inflation","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1191442444","content_text":"With central banks riding a hawkish wave in recent months, eyes turned toward the Bank of England and its latest monetary policy decision this morning, which however did not surprise as the central bank voted unanimously to keep interest rates at 0.1% and by a majority of 8-1 to maintain the amount of quantitative easing at £895bn, with outgoing chief economist Haldane again dissenting and voting to reduce the asset purchase target in his final vote before leaving the Bank of England.\n\nSo with inflation surging in the UK as everywhere else, how did the BOE deflect calls to tighten? Simple, like the Fed it said that while inflation may rise above 3%, it will be transitory, to wit: \"CPI inflation is expected to pick up further above the target, owing primarily to developments in energy and other commodity prices,and is likely to exceed 3% for a temporary period\"which means June output is expected to be around 2.5% below its pre-Covid level in the final quarter of 2019. For context, the previous inflation peak was projected to be 2.5%, so yet another significant reflationary rethink.\nAnd once said \"temporary period\" ends, all shall be well, however nobody knows when that will be, just as nobody knows what the\"clear evidence of significant progress\"toward achieving the 2% inflation target is that the BOE needs before tightening policy.\nAnd while the BOE won't issue a fresh round of forecasts until August, they did revise up their second-quarter projection by around 1.5 percentage points from their May projection of 4.3%.\nSome more details from thefull statement:\n\nCommittee’s expectation is that the direct impact of rises in commodity prices on CPI inflation will be transitory.\nOutput in a number of sectors is now around pre-Covid levels, although it remains materially below in others\nDevelopments in global GDP growth have been somewhat stronger than anticipated, particularly in advanced economies\nThe Committee does not intend to tighten monetary policy at least until there is clear evidence that significant progress is being made in eliminating spare capacity and achieving the 2% inflation target sustainably.\nSpare capacity in the economy was expected to be eliminated as activity picked up, and there was expected to be a temporary period of excess demand, before demand and supply returned broadly to balance.\nPolicy should both lean strongly against downside risks to the outlook and ensure that the recovery was not undermined by a premature tightening in monetary conditions.\nMost members judged that the conditions set out in the MPC’s existing policy guidance, which were in any case necessary but not sufficient conditions for any future tightening in monetary policy, were not met.\nBank staff had revised up their expectations for 2021 Q2 GDP growth to 5.5%, from 4.25% at the  time of the May Report. That would be consistent with output in Q2 being less than 4% below its 2019 Q4 level, and projected output in June around 2.5% lower.\nIt was possible that a stronger path for demand would close the output gap somewhat sooner than had previously been expected.\n\nThe market response was muted as the decision appeared to come on the dovish side: the pound reversed modest gains as short-term positioning over a hawkish surprise is unwound. Gilts rise, with 10-year yield down by 3 basis points to 0.75%.\n\nAccording to Bloomberg, in the longer term, and until a shift comes, the pound may stay under pressure especially as it trades below its 21-weekly moving average, a momentum-defining indicator since the pandemic started.\nAt the same time, EUR/GBP rallied as stops were triggered given the transitory-inflation narrative remains and cable dips toward the $1.39 handle. According to Bloomberg,a 15bps rate hike by the BOE is now pushed back to Aug 2022 from June 2022 just before the decision.It remains to be seen whether this is more interest to trade the pound afresh or is it all down to short-term position rebalancing.\nBottom line: today's somewhat dovish statements puts a lot of attention on to the August meeting when we’ll get a full set of new forecasts and learn more about the BOE's thinking; we should also have a clearer sense of how the virus situation is developing once more people are vaccinated.","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":2267,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":312994824,"gmtCreate":1611986916768,"gmtModify":1703757309050,"author":{"id":"3562381348726197","authorId":"3562381348726197","name":"Jasxcjm","avatar":"https://static.tigerbbs.com/30d8e49d33f2e14f0349d94e1a091311","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562381348726197","authorIdStr":"3562381348726197"},"themes":[],"htmlText":"[难过]&nbsp;[难过]&nbsp;[难过]&nbsp;","listText":"[难过]&nbsp;[难过]&nbsp;[难过]&nbsp;","text":"[难过] [难过] [难过]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/312994824","repostId":"2107443272","repostType":2,"isVote":1,"tweetType":1,"viewCount":1838,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":311564925,"gmtCreate":1611815659367,"gmtModify":1703754170927,"author":{"id":"3562381348726197","authorId":"3562381348726197","name":"Jasxcjm","avatar":"https://static.tigerbbs.com/30d8e49d33f2e14f0349d94e1a091311","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562381348726197","authorIdStr":"3562381348726197"},"themes":[],"htmlText":"Apps&nbsp;","listText":"Apps&nbsp;","text":"Apps","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/311564925","repostId":"2106525374","repostType":2,"isVote":1,"tweetType":1,"viewCount":592,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":319148253,"gmtCreate":1611559769272,"gmtModify":1703750897510,"author":{"id":"3562381348726197","authorId":"3562381348726197","name":"Jasxcjm","avatar":"https://static.tigerbbs.com/30d8e49d33f2e14f0349d94e1a091311","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562381348726197","authorIdStr":"3562381348726197"},"themes":[],"htmlText":"It’s time&nbsp;","listText":"It’s time&nbsp;","text":"It’s time","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/319148253","repostId":"2106841299","repostType":2,"repost":{"id":"2106841299","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1611555127,"share":"https://www.laohu8.com/m/news/2106841299?lang=&edition=full","pubTime":"2021-01-25 14:12","language":"en","title":"Australia shares end at 11-month high as country approves Pfizer vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2106841299","media":"Reuters","summary":"* Mining index rises on Fortescue, BHP, and Rio boost   * Trading volumes low ahead of holiday on Tu","content":"<html><body><p>* Mining index rises on Fortescue, BHP, and Rio boost</p><p>   * Trading volumes low ahead of holiday on Tuesday</p><p>   * NZ index closes 0.5% firmer, <a href=\"https://laohu8.com/S/OCA.AU\">Oceania Healthcare</a> top gainer</p><p> (Updates to close)</p><p>   By Harish Sridharan</p><p>   Jan 25 (Reuters) - Australian shares closed higher on Monday after the country's drug regulator approved the Pfizer-BioNTech COVID-19 vaccine for use, while expectations of a $1.9 trillion fiscal stimulus plan to kick-start the U.S economy lifted broader sentiment.</p><p>   Global equity markets have scaled record highs in recent days on bets COVID-19 vaccines will start to reduce the infection rates worldwide and on a stronger U.S. economic recovery under President Joe Biden.</p><p>   The S&amp;P/ASX 200 index    closed 0.4% firmer at its highest since Feb. 25, 2020, after ending 0.3% lower on Friday. Trading volumes remained at just little over half of the 30-day average.</p><p>   The country's medical regulator was <a href=\"https://laohu8.com/S/AONE\">one</a> of the first in the world to complete a comprehensive approval of the Pfizer-BioNTech vaccine, while Australian Health Minister Greg Hunt told reporters that vaccination of priority groups is expected to begin by February-end, at 80,000 doses per week.</p><p>    \"Volumes are low, and there isn't a lot of activity simply because it's Australia day on Tuesday,\" said Brad Smoling, Managing Director of Smoling Stockbroking. </p><p>   \"The market is taking some relief due to the low number of coronavirus cases and the highly acclaimed Pfizer vaccine that will be rolled out in Australia,\" he said. </p><p>   Markets will be closed on Tuesday on account of Australia Day.     </p><p>   Miners    rose nearly 1.1%, and were the biggest boosts to the index with mining giant Rio Tinto    gaining 2.1%,  while rival BHP    rose nearly 0.89%.</p><p>   Technology stocks    advanced 1.1%, with buy-now-pay-later heavyweight Afterpay    rising 1.4%. Aerial imagery services provider <a href=\"https://laohu8.com/S/NEA.AU\">Nearmap</a>    jumped 5.1% and data services company Appen    closed 2.8% firmer.</p><p>   Energy stocks were the biggest drags on the benchmark, down 1.2% to their lowest in nearly two weeks, as prices inched lower on concerns of tepid demand following a rise in U.S. crude inventories and fresh restrictions in China. </p><p>   Woodside Petroleum    and Santos    both shed more than 1%. </p><p>   New Zealand's benchmark S&amp;P/NZX 50 index    rose 0.5% to finish the session at 13,399.1 points. </p><p>   Residential aged-care services provider Oceania Healthcare</p><p>  and business mail services provider Freightways</p><p>  were the top gainers in the benchmark. </p><p> (Reporting by Harish Sridharan in Bengaluru, Editing by Sherry Jacob-Phillips)</p><p>((harish.sridharan@thomsonreuters.com))</p><p> ((For more information on DIARIES &amp; DATA:</p><p>U.S. earnings diary    </p><p>Wall Street Week Ahead     </p><p>Global Economy Week Ahead    ................................................................ For latest top breaking news across all markets            ))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Australia shares end at 11-month high as country approves Pfizer vaccine</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAustralia shares end at 11-month high as country approves Pfizer vaccine\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-01-25 14:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>* Mining index rises on Fortescue, BHP, and Rio boost</p><p>   * Trading volumes low ahead of holiday on Tuesday</p><p>   * NZ index closes 0.5% firmer, <a href=\"https://laohu8.com/S/OCA.AU\">Oceania Healthcare</a> top gainer</p><p> (Updates to close)</p><p>   By Harish Sridharan</p><p>   Jan 25 (Reuters) - Australian shares closed higher on Monday after the country's drug regulator approved the Pfizer-BioNTech COVID-19 vaccine for use, while expectations of a $1.9 trillion fiscal stimulus plan to kick-start the U.S economy lifted broader sentiment.</p><p>   Global equity markets have scaled record highs in recent days on bets COVID-19 vaccines will start to reduce the infection rates worldwide and on a stronger U.S. economic recovery under President Joe Biden.</p><p>   The S&amp;P/ASX 200 index    closed 0.4% firmer at its highest since Feb. 25, 2020, after ending 0.3% lower on Friday. Trading volumes remained at just little over half of the 30-day average.</p><p>   The country's medical regulator was <a href=\"https://laohu8.com/S/AONE\">one</a> of the first in the world to complete a comprehensive approval of the Pfizer-BioNTech vaccine, while Australian Health Minister Greg Hunt told reporters that vaccination of priority groups is expected to begin by February-end, at 80,000 doses per week.</p><p>    \"Volumes are low, and there isn't a lot of activity simply because it's Australia day on Tuesday,\" said Brad Smoling, Managing Director of Smoling Stockbroking. </p><p>   \"The market is taking some relief due to the low number of coronavirus cases and the highly acclaimed Pfizer vaccine that will be rolled out in Australia,\" he said. </p><p>   Markets will be closed on Tuesday on account of Australia Day.     </p><p>   Miners    rose nearly 1.1%, and were the biggest boosts to the index with mining giant Rio Tinto    gaining 2.1%,  while rival BHP    rose nearly 0.89%.</p><p>   Technology stocks    advanced 1.1%, with buy-now-pay-later heavyweight Afterpay    rising 1.4%. Aerial imagery services provider <a href=\"https://laohu8.com/S/NEA.AU\">Nearmap</a>    jumped 5.1% and data services company Appen    closed 2.8% firmer.</p><p>   Energy stocks were the biggest drags on the benchmark, down 1.2% to their lowest in nearly two weeks, as prices inched lower on concerns of tepid demand following a rise in U.S. crude inventories and fresh restrictions in China. </p><p>   Woodside Petroleum    and Santos    both shed more than 1%. </p><p>   New Zealand's benchmark S&amp;P/NZX 50 index    rose 0.5% to finish the session at 13,399.1 points. </p><p>   Residential aged-care services provider Oceania Healthcare</p><p>  and business mail services provider Freightways</p><p>  were the top gainers in the benchmark. </p><p> (Reporting by Harish Sridharan in Bengaluru, Editing by Sherry Jacob-Phillips)</p><p>((harish.sridharan@thomsonreuters.com))</p><p> ((For more information on DIARIES &amp; DATA:</p><p>U.S. earnings diary    </p><p>Wall Street Week Ahead     </p><p>Global Economy Week Ahead    ................................................................ For latest top breaking news across all markets            ))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2106841299","content_text":"* Mining index rises on Fortescue, BHP, and Rio boost   * Trading volumes low ahead of holiday on Tuesday   * NZ index closes 0.5% firmer, Oceania Healthcare top gainer (Updates to close)   By Harish Sridharan   Jan 25 (Reuters) - Australian shares closed higher on Monday after the country's drug regulator approved the Pfizer-BioNTech COVID-19 vaccine for use, while expectations of a $1.9 trillion fiscal stimulus plan to kick-start the U.S economy lifted broader sentiment.   Global equity markets have scaled record highs in recent days on bets COVID-19 vaccines will start to reduce the infection rates worldwide and on a stronger U.S. economic recovery under President Joe Biden.   The S&P/ASX 200 index    closed 0.4% firmer at its highest since Feb. 25, 2020, after ending 0.3% lower on Friday. Trading volumes remained at just little over half of the 30-day average.   The country's medical regulator was one of the first in the world to complete a comprehensive approval of the Pfizer-BioNTech vaccine, while Australian Health Minister Greg Hunt told reporters that vaccination of priority groups is expected to begin by February-end, at 80,000 doses per week.    \"Volumes are low, and there isn't a lot of activity simply because it's Australia day on Tuesday,\" said Brad Smoling, Managing Director of Smoling Stockbroking.    \"The market is taking some relief due to the low number of coronavirus cases and the highly acclaimed Pfizer vaccine that will be rolled out in Australia,\" he said.    Markets will be closed on Tuesday on account of Australia Day.        Miners    rose nearly 1.1%, and were the biggest boosts to the index with mining giant Rio Tinto    gaining 2.1%,  while rival BHP    rose nearly 0.89%.   Technology stocks    advanced 1.1%, with buy-now-pay-later heavyweight Afterpay    rising 1.4%. Aerial imagery services provider Nearmap    jumped 5.1% and data services company Appen    closed 2.8% firmer.   Energy stocks were the biggest drags on the benchmark, down 1.2% to their lowest in nearly two weeks, as prices inched lower on concerns of tepid demand following a rise in U.S. crude inventories and fresh restrictions in China.    Woodside Petroleum    and Santos    both shed more than 1%.    New Zealand's benchmark S&P/NZX 50 index    rose 0.5% to finish the session at 13,399.1 points.    Residential aged-care services provider Oceania Healthcare  and business mail services provider Freightways  were the top gainers in the benchmark.  (Reporting by Harish Sridharan in Bengaluru, Editing by Sherry Jacob-Phillips)((harish.sridharan@thomsonreuters.com)) ((For more information on DIARIES & DATA:U.S. earnings diary    Wall Street Week Ahead     Global Economy Week Ahead    ................................................................ For latest top breaking news across all markets            ))","news_type":1,"symbols_score_info":{"PFE":1}},"isVote":1,"tweetType":1,"viewCount":524,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}